Search

Search Constraints

You searched for: ISSN 2590-0188

Search Results

2. 100P Immunotherapy around the clock: Impact on stage IV melanoma. (December 2022)

5. 103P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of Chinese extensive-stage small cell lung cancer (ORIENTAL): Preliminary safety and efficacy results. (December 2022)

6. 104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research. (December 2022)